BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22462637)

  • 21. Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease.
    Hasani-Ranjbar S; Amoli MM; Ebrahim-Habibi A; Haghpanah V; Hejazi M; Soltani A; Larijani B
    Fam Cancer; 2009; 8(4):465-71. PubMed ID: 19649731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
    Huang YR; Zhang J; Wang JD; Fan XD
    Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroperitoneal paraganglioma with loss of heterozygosity of the von Hippel-Lindau gene: a case report and review of the literature.
    Anno M; Izawa S; Fujioka Y; Matsuzawa K; Saito K; Hikita K; Makishima K; Nosaka K; Takenaka A; Usui T; Yamamoto K
    Endocr J; 2022 Sep; 69(9):1137-1147. PubMed ID: 35466127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
    Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
    Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
    Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients.
    Wu P; Zhang N; Wang X; Ning X; Li T; Bu D; Gong K
    J Hum Genet; 2012 Apr; 57(4):238-43. PubMed ID: 22357542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
    Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
    Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families.
    Zhang J; Huang Y; Pan J; Liu D; Zhou L; Xue W; Chen Q; Dong B; Xuan H
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1211-8. PubMed ID: 18446368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline VHL gene mutations in three Serbian families with von Hippel-Lindau disease.
    Stanojevic BR; Lohse P; Neskovic GG; Damjanovic SM; Novkovic TB; Jovanovic-Cupic SP; Dimitrijević BB
    Neoplasma; 2007; 54(5):402-6. PubMed ID: 17688370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family.
    Yuan P; Sun Q; Liang H; Wang W; Li L; Wang Y; Deng H; Lai L; Chen X; Zhou X
    Cancer Biol Ther; 2016 Jun; 17(6):599-603. PubMed ID: 27057652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a new
    Lenglet M; Robriquet F; Schwarz K; Camps C; Couturier A; Hoogewijs D; Buffet A; Knight SJL; Gad S; Couvé S; Chesnel F; Pacault M; Lindenbaum P; Job S; Dumont S; Besnard T; Cornec M; Dreau H; Pentony M; Kvikstad E; Deveaux S; Burnichon N; Ferlicot S; Vilaine M; Mazzella JM; Airaud F; Garrec C; Heidet L; Irtan S; Mantadakis E; Bouchireb K; Debatin KM; Redon R; Bezieau S; Bressac-de Paillerets B; Teh BT; Girodon F; Randi ML; Putti MC; Bours V; Van Wijk R; Göthert JR; Kattamis A; Janin N; Bento C; Taylor JC; Arlot-Bonnemains Y; Richard S; Gimenez-Roqueplo AP; Cario H; Gardie B
    Blood; 2018 Aug; 132(5):469-483. PubMed ID: 29891534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.
    Vikkath N; Valiyaveedan S; Nampoothiri S; Radhakrishnan N; Pillai GS; Nair V; Pooleri GK; Mathew G; Menon KN; Ariyannur PS; Pillai AB
    Fam Cancer; 2015 Dec; 14(4):585-94. PubMed ID: 25952756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial and genetic researches on three Chinese families with von Hippel-Lindau disease.
    Mao XC; Su ZP; Yu WQ; Zheng WM; Zeng YJ
    Neurol Res; 2009 Sep; 31(7):743-7. PubMed ID: 19133167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
    Whaley JM; Naglich J; Gelbert L; Hsia YE; Lamiell JM; Green JS; Collins D; Neumann HP; Laidlaw J; Li FP
    Am J Hum Genet; 1994 Dec; 55(6):1092-102. PubMed ID: 7977367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
    Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
    Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
    Decker HJ; Neuhaus C; Jauch A; Speicher M; Ried T; Bujard M; Brauch H; Störkel S; Stöckle M; Seliger B; Huber C
    Hum Genet; 1996 Jun; 97(6):770-6. PubMed ID: 8641695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastoma.
    Fu XM; Zhao SL; Gui JC; Jiang YQ; Shen MN; Su DL; Gu BJ; Wang XQ; Ren QJ; Yin XD; Huang WB; Chen XG
    Genet Mol Res; 2015 May; 14(2):4513-20. PubMed ID: 25966224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
    Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.
    Eisenhofer G; Vocke CD; Elkahloun A; Huynh TT; Prodanov T; Lenders JW; Timmers HJ; Benhammou JN; Linehan WM; Pacak K
    Horm Metab Res; 2012 May; 44(5):343-8. PubMed ID: 22438210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.